Investigating the effectiveness of psychotherapy on the recovery of patients with irritable bowel syndrome

effectiveness of exposure-based cognitive behavioral therapy with awareness and emotional expression training in irritable bowel syndrome patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230626058587N1

Enrollment

Registered

2023-07-09

Start date

2023-08-06

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable bowel syndrome. Irritable bowel syndrome

Interventions

Intervention 1: Intervention group: The recipient of exposure-based cognitive behavioral therapy (10 sessions) along with emotional expression and awareness training (3 sessions). Intervention 2: Cont

Eligibility

Sex/Gender

All

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Patients with irritable bowel syndrome based on ROME-IV criteria People with a diploma or higher education

Exclusion criteria

Exclusion criteria: Family history of colon cancer bloody stool History of severe psychiatric illness History of drug and alcohol dependence in the last 2 years History of neurological diseases

Design outcomes

Primary

Measure	Time frame
Severity of symptoms of irritable bowel syndrome. Timepoint: Before the start of psychotherapy, after the end of the last psychotherapy session and one month after the last session for follow-up. Method of measurement: Irritable bowel scoring system questionnaire.;Severity of anxiety and depression. Timepoint: Before the start of psychotherapy, after the end of the last psychotherapy session and one month after the last session for follow-up. Method of measurement: Hospital anxiety and depression scale.;Abdominal and intestinal symptom anxiety. Timepoint: Before the start of psychotherapy, after the end of the last psychotherapy session and one month after the last session for follow-up. Method of measurement: The Visceral Sensitivity Index.;Quality of life. Timepoint: Before the start of psychotherapy, after the end of the last psychotherapy session and one month after the last session for follow-up. Method of measurement: Irritable Bowel Syndrome-Quality of Life Measure (IBS-QOL).	—

Measure

Time frame

Severity of symptoms of irritable bowel syndrome. Timepoint: Before the start of psychotherapy, after the end of the last psychotherapy session and one month after the last session for follow-up. Method of measurement: Irritable bowel scoring system questionnaire.;Severity of anxiety and depression. Timepoint: Before the start of psychotherapy, after the end of the last psychotherapy session and one month after the last session for follow-up. Method of measurement: Hospital anxiety and depression scale.;Abdominal and intestinal symptom anxiety. Timepoint: Before the start of psychotherapy, after the end of the last psychotherapy session and one month after the last session for follow-up. Method of measurement: The Visceral Sensitivity Index.;Quality of life. Timepoint: Before the start of psychotherapy, after the end of the last psychotherapy session and one month after the last session for follow-up. Method of measurement: Irritable Bowel Syndrome-Quality of Life Measure (IBS-QOL).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReyhaneh

Shahid Beheshti University of Medical Sciences

r.rastegar@sbmu.ac.ir+98 21 2243 2526

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026